2017 Outputs

Scientific publications

Hullegie S, Wootton M, Verheij TJ, Thomas-Jones E, Bates J, Hood K, Gal M, Francis NA, Little P, Moore M, Llor C, Pickles T, Gillespie D, Kirby N, Brugman C, Butler CC Clinicians’ interpretations of point of care urine culture versus laboratory culture results: analysis from the four-country POETIC trial of diagnosis of uncomplicated urinary tract infection in primary care. Fam Pract. 1 Mar 2017. doi: 10.1093/fampra/cmx009. [Epub ahead of print] 

Plantinga N, Wittekamp B, Leleu K, Depuydt P, Van den Abeele AM, Brun-Buisson C, Bonten MJM Oral mucosal adverse events with chlorhexidine 2 % mouthwash in ICU. Intensive Care Medicine. April 2016, Volume 42, Issue 4,  pp 620–621 

Posters & Presentations

Maechler F To isolate or not to isolateExtended Spectrum Beta-Lactamases (ESBL) patients: Results from the R-Gnosis WP5 trial. 4th ICPIC. 22 Jun 2017, Geneva, Switzerland

Plantinga N Selective decontamination in European intensive care units; Preliminary results from the R-GNOSIS study. 4th ICPIC. 22 Jun 2017, Geneva, Switzerland

Hernández García M, Leon-Sampredo R, Pérez-Viso B, Morosini Reilly M, Díaz-Agero C, López Fresneña N, Coque T, Bonten MJ, Malhotra-Kumar S, Ruiz-Garbajosa P, Canton Moreno R Primera descripción de aislados de Kluyvera ascorbata productores de OXA-48 detectados en pacientes ingresados en el Hospital Ramón y Cajal. SEIMC 2017. 11 May 2017, Malaga, Spain. P443

González-González A, Merino I, Hernández M, Turrientes C, Pérez-Viso B, López-Fresneña N, Díaz-Agero C, Cantón R, Ruiz-Garbajosa P Distribución de factores de virulencia en E. coli-BLEE ST131 y no-ST131 de pacientes colonizados. Resultados de un programa de vigilancia activa (Proyecto RGNOSIS). SEIMC 2017. 11 May 2017, Malaga, Spain. O665

Plantinga N, Wittekamp B, Brun-Buisson C, Bonten MJ The prevalence of resistance to colistin during selective decontamination in the ICU. 27th ECCMID. 25 Apr 2017, Vienna, Austria. EP0930

Gonzalez Gonzalez A, Merino I, Hernández García M, Turrientes C, López Fresneña N, Díaz-Agero C, Maechler F, Fankhauser C, Kola A, Schrenzel J, Harbarth S, Bonten MJ, Gastmeier P, Canton Moreno R, Ruiz-Garbajosa P Virulence factors distribution among non-ST131 and ST131 ESBL-E. coli in colonized patients. Results from the R-GNOSIS project. 27th ECCMID. 24 Apr 2017, Vienna, Austria. EP0660

Malhotra-Kumar S Is there enough evidence from research on plasmid-encoded antimicrobial resistance to change infection control guidelines? 27th ECCMID. 23 Apr 2017, Vienna, Austria. S Y0267

Turlej-Rogacka A, Schellemans H, Chapelle S, Bryssinck L, Xavier B, Lammens C, Goossens H, Malhotra-Kumar S Comparison of six commercial kits for DNA extraction from human faecal samples. 27th ECCMID. 23 Apr 2017, Vienna, Austria. P1011

Hernández García M, Leon-Sampredo R, Pérez-Viso B, Morosini Reilly M, Díaz-Agero C, López Fresneña N, Coque T, Bonten MJ, Malhotra-Kumar S, Ruiz-Garbajosa P, Canton Moreno R First report of OXA-producing Kluyvera ascorbate isolates recovered from patients admitted in a hospital in Madrid. 27th ECCMID. 23 Apr 2017, Vienna, Austria.OS0289

Wittekamp B, Plantinga N, Brun-Buisson C, Bonten MJ Decontamination of 3rd-generation cephalosporin- and carbapenem-resistant Gram-negative bacteria in ICU patients. 27th ECCMID. 22 Apr 2017, Vienna, Austria. OS0104